By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


OXiGENE, Inc. 

230 Third Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-547-5900 Fax: 781-547-6800



Company News
OXiGENE (OXGN) Announces Third Quarter 2014 Earnings Conference Call And Webcast 10/22/2014 7:32:32 AM
OXiGENE (OXGN) Announces First Patient Enrolled In Phase 1b/2 Study Of Fosbretabulin Combined With Pazopanib In Patients With Advanced Recurrent Ovarian Cancer 10/8/2014 7:08:31 AM
OXiGENE (OXGN) Announces Presentation Of Data From The Phase 2 GOG186I Study At The 15th Biennial Meeting Of The International Gynecologic Cancer Society 10/7/2014 7:21:01 AM
OXiGENE (OXGN) Initiates Phase 2 Study Of Fosbretabulin In Gastrointestinal Neuroendocrine Tumors 9/18/2014 7:42:55 AM
OXiGENE (OXGN) Announces Presentation At The Rodman & Renshaw Conference On September 9 8/27/2014 7:57:33 AM
OXiGENE (OXGN) Reports Second Quarter 2014 Financial Results 8/5/2014 3:10:18 PM
OXiGENE (OXGN) Announces Second Quarter 2014 Earnings Conference Call And Webcast 7/24/2014 9:10:19 AM
OXiGENE (OXGN) Names Experienced Biotech Executive, David J. Chaplin, Ph.D., As President And Chief Executive Officer 5/16/2014 7:14:59 AM
OXiGENE (OXGN) Reports First Quarter 2014 Financial Results 5/7/2014 9:08:45 AM
OXiGENE (OXGN) Announces First Quarter 2014 Earnings Conference Call And Webcast 4/23/2014 8:56:56 AM